2025年
| 英文 | |
|---|---|
| Miyamori D, Nagasaki Y, Yoshida S, Kashima S, Omori W, Itagaki K, & Ito M | Role of regular medical visits in mitigating increased suicide risk during the early COVID-19 pandemic in Kobe, Japan. BMC Prim Care, 26(1), 18. doi:10.1186/s12875-025-02707-2 |
| Miyamori D, Yoshida S, Ikeda K and Ito M | Evaluating antibiotic susceptibility trends in S. pneumoniae and H. influenzae isolates during the COVID-19 pandemic: An interrupted time series analysis of a nationwide antimicrobial resistance database. Journal of Infection and Public Health 18(5), 102707. https://doi.org/https://doi.org/10.1016/j.jiph.2025.102707. |
| Yamada H, Ito M, et al. | Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study. Gut. 2025 Apr 15:gutjnl-2025-335039. doi: 10.1136/gutjnl-2025-335039. Online ahead of print.PMID: 40240063 |
| Kakimoto M, Ikeda K, Miyamori D, Ito M, et al. | In vitro to clinical efficacy: Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 strains. J Infect Chemother. 2025 Apr;31(4):102604. doi: 10.1016/j.jiac.2024.102604. PMID: 39743178 |
| Ito M, Maruyama Y, Terao S, Okubo K, Hidaka K, Sakamoto T, Haruma K. | A new anti-parietal cell antibody titer measurement kit for diagnosis of autoimmune gastritis. Digestion (2025), Online ahead of print, https://doi.org/10.1159/000545454 |
| Yoshida S, Miyamori D & Ito M | Effect of the 2018 Japan floods and COVID-19 pandemic on cognitive decline among atomic bomb survivors in Hiroshima, Japan: a retrospective cohort study. Aging Clin Exp Res 37, 152 (2025). https://doi.org/10.1007/s40520-025-03054-z |
| Zhang R, Danshiitsoodol N, Noda M, Yonezawa S, Kanno K, Sugiyama M. | Stevia Leaf Extract Fermented with Plant-Derived Lactobacillus plantarum SN13T Displays Anticancer Activity to Pancreatic Cancer PANC-1 Cell Line. Int J Mol Sci. 2025. (in press) |
| Miyamori D, Yoshida S, Ito M | Elevated amputation rates in COVID-19 survivors: Insights from a large-scale Japanese cohort study. J Diabetes Investig 2025, 16(8):1551-1560. |
| Miyamori D, Yoshida S, Omori W, Kashima S, Ito M | Impact of COVID-19 on antidepressant prescription: a matched cohort study using the National insurance claims database in Japan. BMC Psychiatry 2025, 25(1):725. |
| Sasaki A, Ito M, et al. | Clinical Features of Invasive Gastric Cancer Developed After Helicobacter pylori Eradication During Regular Endoscopic Surveillance. Digestive Endoscopy 2025 (in press). |
| Yamada G, Miyamori D, Miyashita J | Development and Validation of a Simple 11-item Long COVID Burden Index (LCBI). Journal of Infection and Chemotherapy 2025:102809. |
| 邦文 | |
|---|---|
| 伊藤公訓 | 自己免疫性胃炎 診療の手引き 春間賢 編 （分担執筆）文光堂 2025 |
| 伊藤公訓 | 機能性消化管疾患 Clinical Rehabilitation 34(4) 416-20, 2025. |
| 伊藤公訓 | H. pylori感染症と自己免疫性胃炎の関連性 臨床消化器内科 40(10) 1268-72, 2025. |
| 菅野啓司 | 菅野啓司：胆汁酸の科学, 調剤と情報 2025 (in press) |
|
伊藤公訓 |
薬剤師の質問になんでも答えます ガイドライン2024改訂版で薬剤師が注意を払うのはどのような点でしょうか？Helicobacter Research 28(2) 253-255, 2024. |
| 宮森大輔 | 体重減少-思春期の意図しない食事摂取量の制限による体重減少-. 診断と治療 113(4), 445-448. |
| 伊藤公訓 | 巻頭言：広島大学病院総合診療医センターのご紹介 広島市医師会だより5月号 2025. |
| 伊藤公訓 | 自己免疫性胃炎診断に不可欠な抗壁細胞抗体測定系の新規開発 Gastro-Health Now. 106号 2025.6.15 |
| 伊藤公訓 他 | 日本ヘリコバクター学会によるH. Pylori感染の診断と治療のガイドライン 2024年改訂版のポイント Gastro-Health Now. 107号 2025.9.30 |
| 原田 拓, 宮森 大輔, 伊藤公訓, 田妻進 et al |
プライマリ・ケアで急性腹症を診る『急性腹症診療ガイドライン2025改訂第2版』事例を通じて学ぶプライマリ・ケアにおける要点. プライマリ・ケア 2025, 10(3):40-42. |
